Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges

Abstract

In children and adolescents with conduct disorder (CD), pharmacotherapy is considered when non-pharmacological interventions do not improve symptoms and functional impairment. Risperidone, a second-generation antipsychotic is increasingly prescribed off-label in this indication, but its efficacy and tolerability is poorly studied in CD, especially in young… (More)
DOI: 10.1007/s00787-013-0498-3

1 Figure or Table

Topics

  • Presentations referencing similar topics